Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Brain Research

• Publication date

  2010-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.brainres.2009.11.012PMID 19913518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.

  2009cited by this paper
• Chain of Survival

  2009cited by this paper
• Therapeutic Benefits by Human Mesenchymal Stem Cells (hMSCs) and Ang-1 Gene-Modified hMSCs after Cerebral Ischemia

  2008cited by this paper
• Role of the brain‐derived neurotrophic factor at glutamatergic synapses

  2008cited by this paper
• Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses

  2008influential reference
• Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.

  2008cited by this paper
• Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats.

  2007cited by this paper
• Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model.

  2007cited by this paper
• Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model

  2007cited by this paper
• Potential Treatment of Cerebral Global Ischemia with Oct‐4+ Umbilical Cord Matrix Cells

  2007cited by this paper
• Selective Dysfunction of Hippocampal CA1 Astrocytes Contributes to Delayed Neuronal Damage after Transient Forebrain Ischemia

  2007cited by this paper
• Progesterone increases brain‐derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen‐activated protein kinase‐ and phosphoinositide‐3 kinase‐dependent manner in cerebral cortical explants

  2007cited by this paper
• Mesenchymal Stem Cells Derived from Peripheral Blood Protects against Ischemia

  2007cited by this paper
• Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells.

  2006cited by this paper
• Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

  2006influential reference
• Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat

  2006influential reference
• Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.

  2006influential reference
• I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

  2005influential reference
• Autologous mesenchymal stem cell transplantation in stroke patients

  2005cited by this paper
• Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways

  2005cited by this paper
• Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.

  2005cited by this paper
• BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.

  2004cited by this paper
• A newborn piglet study of moderate hypoxic-ischemic brain injury by 1H-MRS and MRI.

  2004cited by this paper
• A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.

  2004influential reference
• In, out, shake it all about: elevation of [Ca2+]i during acute cerebral ischaemia.

  2004cited by this paper
• The neurological and cognitive sequelae of cardiac arrest

  2004cited by this paper
• Immunohistochemical identification of multipotent adult progenitor cells from human bone marrow after transplantation into the rat brain.

  2003cited by this paper
• Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells.

  2003cited by this paper
• Time course of circulatory and metabolic recovery of cat brain after cardiac arrest assessed by perfusion- and diffusion-weighted imaging and MR-spectroscopy.

  2003cited by this paper
• Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery

  2002influential reference
• [Current state on development of neuroprotective agents for cerebral ischemia].

  2002cited by this paper
• Regional Dependence of Cerebral Reperfusion after Circulatory Arrest in Rats

  2001cited by this paper
• Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats.

  2001cited by this paper
• From marrow to brain: expression of neuronal phenotypes in adult mice.

  2000cited by this paper
• Adult bone marrow stromal cells differentiate into neural cells in vitro.

  2000cited by this paper
• CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice.

  2000cited by this paper
• Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral Ischemia

  2000cited by this paper
• Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challenge

  1999cited by this paper
• Neuroprotection by Brain-derived Neurotrophic Factor Is Mediated by Extracellular Signal-regulated Kinase and Phosphatidylinositol 3-Kinase*

  1999cited by this paper
• Phenotypic and functional comparison of cultures of marrow‐derived mesenchymal stem cells (MSCs) and stromal cells

  1998cited by this paper
• Proton T2 relaxation of cerebral metabolites during transient global ischemia in rat brain

  1998influential reference
• Effects of severe global ischemia on N‐acetylaspartate and other metabolites in the rat brain

  1997cited by this paper
• Survivors of out of hospital cardiac arrest: their prognosis, longevity and functional status.

  1997cited by this paper
• Potentiated necrosis of cultured cortical neurons by neurotrophins.

  1995cited by this paper
• Dynamic monitoring of cerebral metabolites during and after transient global ischemia in rats by quantitative proton NMR spectroscopy in vivo

  1995cited by this paper
• Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2.

  1994cited by this paper
• Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients

  1992cited by this paper
• Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association.

  1991cited by this paper
• Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.

  1991cited by this paper
• Cerebroprotective effects of flunarizine in an experimental rat model of cardiac arrest.

  1990cited by this paper
• Ionic dependence of glutamate neurotoxicity

  1987cited by this paper
• Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain

  1985cited by this paper
• An experimental circulatory arrest model in the rat to evaluate calcium antagonists in cerebral resuscitation.

  1984cited by this paper
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

  1984cited by this paper
• Spatial memory and hippocampal function.

  1979cited by this paper

• From Brain to Lung: Emerging Insights into Mesenchymal Stem Cell-Derived Extracellular Vesicle-Associated Cargos in Ischemia-Reperfusion Injury

  2025cites this paper
• Cross-organ protection of MSC-derived extracellular vesicles in ischemia-reperfusion injury: angiogenic synergy in kidney, brain, and heart

  2025cites this paper
• Systemic Administration of Allogeneic Mesenchymal Stem Cells Attenuates Post-Resuscitation Left Ventricular Dysfunction in a Porcine Model of Cardiac Arrest.

  2025cites this paper
• Reversing coma by senolytics and stem cells: the future is now

  2025cites this paper
• Mesenchymal Stem Cell Therapy for Cardiac Arrest: Promise, Challenges, and the Path Forward.

  2025cites this paper
• Transplantation of Exosomes Derived From Human Wharton’s Jelly Mesenchymal Stromal Cells Enhances Functional Improvement in Stroke Rats

  2024cites this paper
• Intravenous infusion of auto-serum-expanded autologous mesenchymal stem cells into chronic severe brain injury patients

  2023cites this paper
• Neuroprotection of Stem Cells Against Ischemic Brain Injury: From Bench to Clinic

  2023cites this paper
• Dose-Dependent Effects of Intravenous Mesenchymal Stem Cell Transplantation in Rats with Acute Focal Cerebral Ischemia

  2022cites this paper
• Mesenchymal Stem Cells for Neurological Disorders

  2021cites this paper
• Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases

  2021cites this paper
• Intravenous Delivery of Mesenchymal Stem Cells Protects both White and Gray Matter in Spinal Cord Ischemia.

  2020cites this paper
• Imaging as a tool to accelerate the translation of extracellular vesicle-based therapies for central nervous system diseases.

  2020cites this paper
• Optimizing Stem Cell Therapy after Ischemic Brain Injury

  2020cites this paper
• Dose-effect relationship and molecular mechanism by which BMSC-derived exosomes promote peripheral nerve regeneration after crush injury

  2020cites this paper
• Bone marrow-mesenchymal stem cells modulate microglial activation in the peri-infarct area in rats during the acute phase of stroke.

  2019cites this paper
• Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction.

  2019cites this paper
• Immortalized Human Bone Marrow Derived Stromal Cells in Treatment of Transient Cerebral Ischemia in Rats

  2019cites this paper
• Diabetic neuropathy research: from mouse models to targets for treatment

  2019cites this paper
• Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brain

  2018cites this paper
• Early IV‐injected human dermis‐derived mesenchymal stem cells after transient global cerebral ischemia do not pass through damaged blood–brain barrier

  2018cites this paper
• Cerebral ischemia and neuroregeneration

  2018cites this paper
• Administration of placenta-derived mesenchymal stem cells counteracts a delayed anergic state following a transient induction of endogenous neurogenesis activity after global cerebral ischemia.

  2018cites this paper
• [Cell therapy for ischemic stroke. Stem cell types and results of pre-clinical trials].

  2018cites this paper
• Effects of labeling human mesenchymal stem cells with superparamagnetic iron oxides on cellular functions and magnetic resonance contrast in hypoxic environments and long-term monitoring

  2018cites this paper
• Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats.

  2018cites this paper
• Bone marrow mesenchymal stem cells repair the hippocampal neurons and increase the expression of IGF-1 after cardiac arrest in rats

  2017cites this paper
• Gelatin-based 3D conduits for transdifferentiation of mesenchymal stem cells into Schwann cell-like phenotypes.

  2017cites this paper
• Effect of Adipose-Derived Mesenchymal Stem Cell Administration and Mild Hypothermia Induction on Delayed Neuronal Death After Transient Global Cerebral Ischemia

  2017cites this paper
• Transplantation with hypoxia‐preconditioned mesenchymal stem cells suppresses brain injury caused by cardiac arrest–induced global cerebral ischemia in rats

  2017cites this paper
• Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke

  2017cites this paper
• Proteomic analysis of mesenchymal to Schwann cell transdifferentiation.

  2017cites this paper
• Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke

  2017cites this paper
• Post-ischemic Intravenous Administration of Allogeneic Dental Pulp-Derived Neurosphere Cells Ameliorated Outcomes of Severe Forebrain Ischemia in Rats

  2017influential citation
• Therapeutic effect by combining rehabilitation and intravenous infusion of mesenchymal stem cells after experimental stroke in rats

  2017cites this paper
• The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke

  2016cites this paper
• Intravenously Infused F3.Olig2 Improves Memory Deficits via Restoring Myelination in the Aged Hippocampus following Experimental Ischemic Stroke

  2016cites this paper
• Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury.

  2016cites this paper
• Intravenous Injection of Clinical Grade Human MSCs after Experimental Stroke: Functional Benefit and Microvascular Effect

  2016cites this paper
• The potential role of bone marrow mesenchymal stromal cells in the treatment of ischemic stroke

  2016cites this paper
• Conditioned Medium Derived from Neural Progenitor Cells Induces Long-term Post-ischemic Neuroprotection, Sustained Neurological Recovery, Neurogenesis, and Angiogenesis

  2016cites this paper
• Influence of rat adipose tissue-derived mesenchymal stem cells on brain tissues following permanent unilateral common carotid artery occlusion in adult male albino rat: a histological and immunohistochemical study

  2016cites this paper
• Stem Cells, Bioengineering, and 3-D Scaffolds for Nervous System Repair and Regeneration

  2016cites this paper
• Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats

  2016cites this paper
• Therapeutic effects of various methods of MSC transplantation on cerebral resuscitation following cardiac arrest in rats

  2016cites this paper
• Acellular allogeneic nerve grafting combined with bone marrow mesenchymal stem cell transplantation for the repair of long-segment sciatic nerve defects: biomechanics and validation of mathematical models

  2016cites this paper
• Effect of Extracellular Vesicles on Neural Functional Recovery and Immunologic Suppression after Rat Cerebral Apoplexy

  2016cites this paper
• Neuroprotection for ischaemic stroke: current status and challenges.

  2015cites this paper
• Enabling Technologies for Cell-Based Clinical Translation Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression

  2015cites this paper
• Adipose‐Derived Mesenchymal Stem Cells Reduce Neuronal Death After Transient Global Cerebral Ischemia Through Prevention of Blood‐Brain Barrier Disruption and Endothelial Damage

  2015cites this paper
• [Treatment of cerebral ischemia using mesenchymal stem cell-clinical trial phase III].

  2015cites this paper
• Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

  2015cites this paper
• Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.

  2015cites this paper
• Primary Bone Marrow Mesenchymal Stromal Cells Rescue the Axonal Phenotype of Twitcher Mice

  2014cites this paper
• Bone marrow stromal cells as a therapeutic treatment for ischemic stroke

  2014cites this paper
• Effects of neural progenitor cells on post-stroke neurological impairment—a detailed and comprehensive analysis of behavioral tests

  2014cites this paper
• Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice

  2014cites this paper
• Effect of adipose derived mesenchymal stem cells administration and therapeutic induction of hypothermia on delayed neuronal death after transient global cerebral ischemia

  2014cites this paper
• Bone Marrow Mesenchymal Stem Cell-Derived Microvesicles Protect Rat Pheochromocytoma PC12 Cells from Glutamate-Induced Injury via a PI3K/Akt Dependent Pathway

  2014cites this paper
• De novo expression of fetal ED-A+ fibronectin and B+ tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection

  2014cites this paper
• Mesenchymal stem cells transplantation suppresses inflammatory responses in global cerebral ischemia: contribution of TNF-α-induced protein 6

  2013cites this paper
• Magnetic resonance contrast and biological effects of intracellular superparamagnetic iron oxides on human mesenchymal stem cells with long-term culture and hypoxic exposure.

  2013cites this paper
• Update on Therapeutic Mechanism for Bone Marrow Stromal Cells in Ischemic Stroke

  2013cites this paper
• Current Perspectives on Molecular Imaging for Tracking Stem Cell Therapy

  2013cites this paper
• Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats.

  2013cites this paper
• Generation of hydrogen peroxide mediates hanging death-induced neuronal cell apoptosis in the dentate gyrus of the rat brain.

  2013cites this paper
• Monitoring Bone Marrow Stem Cells with a Reporter Gene System in Experimental Middle Cerebral Artery Occlusion Rat Models

  2013cites this paper
• Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system

  2013cites this paper
• Mesenchymal Stem Cells as Gene Delivery Vehicles

  2013cites this paper
• Human mesenchymal stem cells increases expression of α-tubulin and angiopoietin 1 and 2 in focal cerebral ischemia and reperfusion.

  2013cites this paper
• p53 activation and mitochondria-mediated pathway are involved during hanging death-induced neuronal cell apoptosis in dentate gyrus region of the rat brain

  2013cites this paper
• Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.

  2013cites this paper
• Drug Delivery using genetically modified Mesenchymal Stem Cells: A promising targeted-delivery method

  2013cites this paper
• Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

  2013cites this paper
• Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation

  2012cites this paper
• Chlorogenic acid protects MSCs against oxidative stress by altering FOXO family genes and activating intrinsic pathway.

  2012cites this paper
• Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone‐treated parkinsonian mice

  2012cites this paper
• Update on stem cell therapy for cerebral palsy

  2011cites this paper
• Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

  2011cites this paper
• Drugs during cardiopulmonary resuscitation

  2011cites this paper
• The Effect of Wound Fluid on Adipose-Derived Stem Cells In Vitro: A Study in Human Cell Materials

  2011cites this paper
• Neuroprotective properties of marrow‐isolated adult multilineage‐inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers

  2011influential citation
• Systemic Delivery of Bone Marrow‐Derived Mesenchymal Stromal Cells Diminishes Neuropathology in a Mouse Model of Krabbe's Disease

  2011cites this paper
• Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

  2010cites this paper
• Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.

  2010cites this paper
• Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

  2010cites this paper
• Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities

  2010cites this paper
• Cellular Neuroscience Mini Review Article Stem Cell-based Treatments against Stroke: Observations from Human Proof-of-concept Studies and Considerations regarding Clinical Applicability

  year unknowncites this paper
• Stem cell types and results of preclinical trials

  year unknowncites this paper
• Frontier hot trends in ischemic stroke and vascular regeneration based on bibliometric analysis

  year unknowncites this paper